BSE Live
Feb 20, 13:55Prev. Close
226.60
Open Price
225.00
Bid Price (Qty.)
223.80 (259)
Offer Price (Qty.)
224.15 (1)
NSE Live
Feb 20, 13:55Prev. Close
226.47
Open Price
225.10
Bid Price (Qty.)
223.87 (6)
Offer Price (Qty.)
224.14 (159)
| Cash Flow of Bliss GVS Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 121.71 | 120.01 | 86.84 | 94.91 | 100.21 | |
| Net CashFlow From Operating Activities | 58.03 | 48.29 | 22.67 | 38.48 | 59.61 | |
| Net Cash Used In Investing Activities | -57.89 | -68.04 | 16.36 | -29.34 | -10.29 | |
| Net Cash Used From Financing Activities | -2.86 | 9.05 | -21.91 | -14.70 | -35.34 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | -4.43 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.72 | -10.70 | 17.12 | -5.56 | 9.55 | |
| Cash And Cash Equivalents Begin of Year | 13.75 | 24.45 | 7.33 | 12.89 | 3.40 | |
| Cash And Cash Equivalents End Of Year | 11.03 | 13.75 | 24.45 | 7.33 | 12.95 |
20.02.2026
Bliss GVS Consolidated December 2025 Net Sales at Rs 218.25 crore, up 3.72% Y-o-Y
19.02.2026
Bliss GVS Standalone December 2025 Net Sales at Rs 164.68 crore, down 8.3% Y-o-Y
07.11.2025
Bliss GVS Consolidated September 2025 Net Sales at Rs 244.40 crore, up 12.27% Y-o-Y
30.07.2025
Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y